Wall Street Zen Downgrades Tenet Healthcare (NYSE:THC) to Buy

Tenet Healthcare (NYSE:THC) was downgraded by investment analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday.

A number of other analysts also recently commented on THC. Guggenheim raised their price objective on Tenet Healthcare from $257.00 to $271.00 and gave the stock a “buy” rating in a research report on Friday, February 13th. TD Cowen reaffirmed a “buy” rating on shares of Tenet Healthcare in a research report on Thursday, February 12th. Cantor Fitzgerald boosted their price target on shares of Tenet Healthcare from $190.00 to $245.00 and gave the company an “overweight” rating in a report on Wednesday, October 29th. Raymond James Financial set a $245.00 price objective on shares of Tenet Healthcare in a report on Wednesday, October 29th. Finally, KeyCorp upped their target price on shares of Tenet Healthcare from $225.00 to $250.00 and gave the company an “overweight” rating in a research note on Thursday, February 12th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, Tenet Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $247.67.

Tenet Healthcare Trading Up 0.6%

Shares of THC stock opened at $229.56 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18. Tenet Healthcare has a 1 year low of $109.82 and a 1 year high of $235.77. The firm’s fifty day simple moving average is $201.87 and its 200 day simple moving average is $197.17. The firm has a market capitalization of $19.96 billion, a P/E ratio of 14.82, a price-to-earnings-growth ratio of 1.12 and a beta of 1.44.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. During the same period last year, the business posted $3.44 EPS. The business’s quarterly revenue was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, sell-side analysts predict that Tenet Healthcare will post 12.24 EPS for the current year.

Insider Buying and Selling

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of the company’s stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $197.47, for a total transaction of $430,089.66. Following the sale, the director directly owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. This represents a 7.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.81% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Tenet Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the business. Norges Bank bought a new stake in shares of Tenet Healthcare during the fourth quarter worth $248,494,000. Eminence Capital LP acquired a new stake in Tenet Healthcare in the third quarter worth about $225,263,000. Boston Partners raised its holdings in Tenet Healthcare by 95.0% during the 2nd quarter. Boston Partners now owns 2,267,142 shares of the company’s stock worth $398,949,000 after purchasing an additional 1,104,500 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of Tenet Healthcare by 1,114.2% in the 4th quarter. Wellington Management Group LLP now owns 1,135,801 shares of the company’s stock valued at $225,706,000 after purchasing an additional 1,042,260 shares during the last quarter. Finally, AQR Capital Management LLC grew its position in shares of Tenet Healthcare by 62.3% during the 3rd quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock worth $380,989,000 after buying an additional 720,160 shares during the period. 95.44% of the stock is owned by institutional investors and hedge funds.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.